Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma. [electronic resource]
Producer: 20170424Description: 1135-1143 p. digitalISSN:- 1523-1747
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Synergism
- Extracellular Signal-Regulated MAP Kinases -- antagonists & inhibitors
- Humans
- Indazoles -- administration & dosage
- Melanoma -- drug therapy
- Mutation
- Neurofibromin 1 -- genetics
- Oxygen Consumption -- drug effects
- Phenformin -- administration & dosage
- Piperazines -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.